- The digital renminbi is a sovereign currency fully backed by the state, does not require a bank account and has full oversight by Chinese banking authorities
- Developing countries will embrace the convenience of China’s digital payment systems, which have great poverty-relief potential for the world’s unbanked poor
DISCLAIMER This information represents neither an offer to buy or sell any security nor, because it does not take into account the differing needs of individual clients, investment advice. Those seeking investment advice specific to their financial profiles and goals should contact their Oscar Gruss & Son Incorporated sales representative. Oscar Gruss & Son Incorporated believes this information to be reliable, but no representation is made as to accuracy or completeness. This information does not analyze every material fact concerning a company, industry, or security. Oscar Gruss & Son Incorporated assumes that this information will be read in conjunction with other publicly available data. Matters discussed here are subject to change without notice. There can be no assurance that reliance on the information contained here will produce profitable results. A security denominated in a foreign currency is subject to fluctuations in currency exchange rates, which may have an adverse effect on the value of the security upon the conversion into local currency of dividends, interest, or sales proceeds. The value of securities and depositary receipts of foreign issuers that are denominated in United States dollars are also influenced by fluctuations in currency exchange rates. © 2020 Oscar Gruss & Son Incorporated. All rights reserved.BWACU First Day for Separate Trading of Common Stock and Warrants (under the BWAC and BWACU symbols on Nasdaq)
CIIC/Arrival CIIC 2020 Annual Meeting (to vote on the election of 2 directors) 10:00am ET
LOAK/Danimer LOAK S/H Vote Date 10:00am ET
RMG/Romeo Systems RMG S/H Vote Date 10:00am ET
TOTA/Clene TOTA Shareholder Redemption Deadline 4:00am ET
VCVCU First Day of Separate Trading for Common Stock and Warrants (under the VCVC and VCVCW symbols on Nasdaq
S-1/A#3 filed, terms unchanged
S-1/A#1 filed, exhibits
SPACs Business Combinations
Israeli fintech company, eToro, a social trading and multi-asset brokerage company, is on its way to an initial public offering on Nasdaq at a valuation of $5 billion. The company is currently in talks with investment bank Goldman Sachs regarding leading the IPO. The IPO is scheduled to be completed during the second quarter of 2021. eToro is set to join an ever-growing list of Israeli tech companies embarking on a U.S. IPO in the coming months, including ironSource, Monday.com, OrCam, Payoneer, REE, Taboola, and Outbrain. Similarly to some of those aforementioned companies, eToro is also examining the possibility of completing a SPAC (special-purpose acquisition company) merger in order to hasten its entrance to Wall Street.
Calcalist: Ree in talks to go public, no specific SPAC mentioned
Calcalist has learned that REE Automotive, which is developing a revolutionary platform for electric and autonomous vehicles, is negotiating a merger with the American company SPAC, valued at $ 4-3 billion. The talks, which have been going on for more than three months, were supposed to end in late 2020 but They will likely be extended until January 2021.
NY Post: This plastic maker has big companies thirsting for its technology
Gapping down
In reaction to earnings/guidance:
- WB -1.5%
Other news:
- NNDM -11.1% (prices offering of 33,333,334 of the Company's American Depositary Shares at a price of $7.50 per ADS)
- BABA -1.5% (Chinese gov't tighten restrictions on Ant Grp; shares fall in Hong Kong)
- VXX -1.2% (trading lower with strength in US futures)
Analyst comments:
- OCUL -2.9% (downgraded to Neutral from Buy at H.C. Wainwright)
- CNSP -2.8% (downgraded to Neutral from Buy at Ladenburg Thalmann)
Gapping up
Select index ETFs showing strength:
- IWM +1.5%, SPY +0.7%, QQQ +0.7%, DIA +0.6%
Other news:
- MYOV +20% (Myovant Sciences and Pfizer (PFE) to collaborate to develop and commercialize Relugolix)
- IDEX +15.9% (announces purchase agreement for 2,000 units of D1, BYD's custom electric ride-hailing vehicle)
- IMV +8.9% (provides update on COVID-19 vaccine program; Preclinical safety, long duration of antibody titers and potential for protection demonstrated in preclinical immunogenicity and challenge studies)
- AZN +4.3% (AstraZeneca and Merck (MRK) receive retrieve approval in Japan for Lynparza treatment of advanced ovarian, prostate and pancreatic cancers)
- CCM +3% (announces divestment of Singapore Concord International Hospital)
- KTOS +2.2% (Kratos Defense and Security announced today that Kratos will receive an additional $3,570,194 from the U.S. Navy for the next option of its Contractor Logistics Support (CLS) and Engineering Services contract supporting BQM-177A aerial target system operations)
- CARA +1.9% (submits new drug application to FDA for Korsuva injection in hemodialysis patients with moderate-to-severe pruritus)
- HGEN +1.9% (secures US patent for lenzilumab in preventing cytokine storm and neurotoxicity related to CAR-T Cell Therapy)
- FHN +1.3% (provides results of company-run stress test)
Analyst comments:
- KNTE +7.8% (initiated with a Buy at Goldman, among others)
- AMST +6.8% (initiated with a Speculative Buy at The Benchmark Company)
- PAE +1.2% (initiated with an Overweight at Morgan Stanley)
Early premarket gappers
- Gapping up:
- MYOV +27.5%, DPW +15.5%, AZN +4.1%, IWM +1.4%, MRK +1.1%, SPY +0.7%, QQQ +0.6%, DIA +0.6%
- Gapping down:
- NNDM -13.5%, WB -1.5%, VXX -1.1%, BABA -0.7%